Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PEA15 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | SPDYE16 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | SERAC1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | ALOX12 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | CARD19 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | NAPRT | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | LRRC36 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | KIAA1191 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | STX5 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | RIPK4 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |